The emerging landscape of novel 4-1BB (CD137) agonistic drugs for cancer immunotherapy
Christina Claus(Roche (Switzerland)), Christian Klein(Medizinische Hochschule Hannover)
Cited by 92
Related Papers
ME3738 protects from concanavalin A‐induced liver failure via an IL‐6‐dependent mechanism
|European Journal of Immunology|2003|28
The IL-6–gp130–STAT3 pathway in hepatocytes triggers liver protection in T cell–mediated liver injury
|Journal of Clinical Investigation|2005|27